Pr Christophe Massard, Oncologue médical, expert vessie, expert prostate

Spécialité

Oncologue médical, expert vessie, expert prostate

Titre

Chef du Département des Essais Précoces (DITEP)

Hôpital

Gustave Roussy (Villejuif)

Derniers articles

[Proposals to develop innovation and research in cancer and optimize care for patients affected by cancer]. (1 sept. 2025)
The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients. (26 août 2025)
[TRANSFORM-O: A new training program in translational research offered by the French Society of Cancer (SFC) and the French National College of Oncology Teachers (CNEC)]. (20 août 2025)
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. (31 juil. 2025)
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers. (29 juil. 2025)